Menu

Corbus Pharmaceuticals Holdings, Inc. CRBP

Full chart Compare
Set alert

Price alert · CRBP

All alert types
3.73 USD +0.21 (+5.82%)

Nov 10, 2026, 1:04 PM EST

3.21 Day range 3.76
2.81 52-week range 12.88
YTD
-54.24%
1 year
-64.39%

Revenue & Expenses

Other Income → Expenses: $10.44MExpenses → Gross Loss: $757.53KExpenses → Selling, General & Admin: $20.43MExpenses → Research & Development: $36.45MOther Operating Income → Expenses: $1.64MNet Loss → Expenses: $45.55MRevenue → Cost of Revenue: $881.71KOther Income$10.44MOther Operating Income$1.64MNet Loss$45.55MCost of Revenue$1.64MExpenses$57.63MGross Loss$757.53KSelling, General & Admin$20.43MResearch & Development$36.45MRevenue$881.71K

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

CRBP annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
85.31M48.72M45.08M39.84M56.87M
70.09M32.22M31.17M16.14M36.45M
15.21M16.50M13.91M18.70M20.43M
-85.31M-48.72M-45.08M-39.84M-55.99M
-78.54M-40.21M-44.60M-42.35M-45.64M
-78.54M-40.21M-44.60M-42.35M-45.64M
-78.54M-40.21M-44.60M-42.35M-45.64M
-78.54M-40.21M-44.60M-42.35M-45.64M
-5.90-3.68-10.31-10.15-11.15
-5.90-3.68-10.31-10.15-11.15
-5.90-3.68-10.31-10.15-11.15
-78.54M-38.34M-40.75M-40.21M-43.81M
-78.54M-38.34M-40.75M-40.21M-43.81M
13.32M10.92M4.33M4.17M4.09M
13.32M10.92M4.33M4.17M4.09M